The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•2 March 2026•

1 min read

Visionary Holdings Pivots to Medical Aesthetics with $12M Deal and Education Exit

Donald Trump in a suit stands before the White House. Lab equipment, molecular models, and a signed "BIOTECH GROWTH INITIATIVE" executive order are in the foreground. Green glowing lines, a growth cha

Key Facts

1Visionary Holdings signed a $12 million exclusive distribution agreement for its anti-aging product with Huajin China Investment Company.

Visionary Holdings Inc. (NASDAQ: GV) has announced a significant $12 million exclusive distribution agreement for its 'President Super Injection' anti-aging product with Huajin China Investment Company. This deal marks a major milestone in the company's strategic pivot toward the high-margin medical aesthetics and biotechnology sectors. In a simultaneous move, the company’s board of directors approved a strategic exit from its non-core education business to streamline operations and focus resources. The divestiture is designed to allow the firm to concentrate entirely on healthcare and biotechnology innovations. Management expects the new distribution agreement to provide a substantial revenue boost and long-term growth opportunities for shareholders. This restructuring highlights Visionary Holdings' commitment to optimizing its portfolio for higher profitability and market competitiveness.